---
title: Piramal Pharma Solutions vs WuXi XDC
slug_a: piramalpharmasolutions
slug_b: wuxi-xdc
site: cdmo
review_signal_gate: closed
canonical_path: /compare/piramalpharmasolutions/wuxi-xdc
---

# Piramal Pharma Solutions vs WuXi XDC

Side-by-side profile data from each company listing on this directory.

## Piramal Pharma Solutions

- Profile: [/companies/piramalpharmasolutions](/companies/piramalpharmasolutions)

Piramal Pharma Solutions — CDMO specializing in HPAPIs, ADCs, peptides, vaccines, and biologics with 4,700+ team members across 15 global sites and 500+ customers. Offers integrated development and manufacturing with backward integration capabilities and global program management.

Services: 18. Modalities: 5. Indications: 0. Locations: 3. Certifications: 7. The strongest documented coverage currently appears in services (18).

### Services

- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Controlled Substance Manufacturing
- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- ADC Payload & Linker Synthesis
- Bioconjugation Services
- Peptide Manufacturing
- Vaccine Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Oral Solid Dosage Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Peptide
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Oral Solid Dose (OSD)
- HPAPI
- DEA licensed

## WuXi XDC

- Profile: [/companies/wuxi-xdc](/companies/wuxi-xdc)

WuXi XDC — WuXi XDC is a leading CRDMO offering integrated discovery, development, and cGMP manufacturing services for antibody drug conjugates (ADCs) and bioconjugates, with proximately located facilities that reduce development timelines and costs.

Services: 12. Modalities: 2. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (12).

### Services

- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- ADC Payload & Linker Synthesis
- Bioconjugation Services
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Lyophilization (Freeze Drying)
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development

### Modalities

- Biologics (Monoclonal Antibodies)
- Antibody-Drug Conjugate (ADC)

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials
- Expression: Mammalian